ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag tuberculosis biotech pharma business genetics genomics

2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Start It Up
Dan Cossins | Apr 1, 2013 | 8 min read
Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
The Growth of Iowa Biotech
Jenny Rood | Aug 1, 2016 | 7 min read
The state’s industry draws inspiration from medicine as well as agriculture.
Best Places to Work Industry 2013
The Scientist | Jun 1, 2013 | 6 min read
Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
A fruit bat in the hands of a researcher
How an Early Warning Radar Could Prevent Future Pandemics
Amos Zeeberg, Undark | Feb 27, 2023 | 8 min read
Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.
Opinion: Talking Genomics
Trevor Quirk | Nov 13, 2012 | 5 min read
The crucial importance of language in the debate over the regulation of direct-to-consumer genetic tests
Research in the Business World
Karen Young Kreeger | Oct 15, 2000 | 5 min read
As more universities negotiate licensing agreements with biotech firms and big Pharma, unprecedented numbers of life scientists move between the Ivory Tower and industrial labs. Are the worlds of academia and industry colliding or meshing? How does the bottom line govern what science gets done? Although answers will vary from company to company, say life science researchers based in private sector research, there are more similarities than some might think. Lee Rubin, senior vice presiden
Pharma goes open access
Stephen Pincock | Feb 25, 2007 | 4 min read
Novartis shares diabetes genomic data, and experts say there's more to come
A twisted and folded illustration of single-stranded RNA in front of a blue background.
Deficient RNA Editing Implicated in Inflammatory Disease 
Alejandra Manjarrez, PhD | Aug 5, 2022 | 3 min read
Genetic variants that reduce the editing levels of double-stranded RNA are associated with autoimmune and immune-mediated conditions, a study finds.

Run a Search

ADVERTISEMENT